Award
Delivery Order #80JSC027FA008
Delivery Order for Bioengineering Tumor Organoid Nanobioreactors in Space
Buyer
National Aeronautics and Space Administration
Award Amount
$580,000.00
Ceiling
$580,000.00
Awarded
October 13, 2026
Period of Performance
Oct 13, 2026 – Jun 30, 2028
Identifier
80JSC027FA008
NAICS
541714
This award is a delivery order contract granted to STI Legacy, Inc., a U.S.-owned small business specializing in manufacturing and research and development products. The contract focuses on the bioengineering of human tumor organoid nanobioreactors for experimental use in space environments, supporting innovative biomedical research in microgravity. It is part of an ongoing NASA initiative to advance space-based pharmaceutical and biological sciences, enhancing understanding of human health in space. The scope includes the development, delivery, and implementation of nanobioreactor technologies designed for orbit-based experimentation. This award follows a larger IDIQ contract previously awarded to the same company, reflecting NASA's continued investment in this area. The contract was awarded competitively under the umbrella of the existing IDIQ agreement and marks a significant extension of STI Legacy's contribution to space biotechnologies. The period of performance spans nearly two years, starting in late 2026 and concluding mid-2028, emphasizing a focused timeline for project milestones within NASA's research agenda.
Description
BIOENGINEERING HUMAN TUMOR ORGANOID NANOBIOREACTORS IN SPACE